selected publications
- Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression. Life science alliance. 2020 Academic Article GET IT
- GATA1 downregulation in prefibrotic and fibrotic stages of primary myelofibrosis and in the myelofibrotic progression of other myeloproliferative neoplasms. Leukemia research. 2020 Academic Article GET IT
- Clinical Laboratory Validation and Implementation of Quantitative, Real-Time PCR-based Detection of NPM1 Type A Mutation. Clinical laboratory. 2020 Academic Article GET IT
- XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53. Journal of hematology & oncology. 2020 Letter GET IT
- T-cell neoplasms in the spleen. Seminars in diagnostic pathology. 2020 Review GET IT
- Longitudinal immune profiling of mild and severe COVID-19 reveals innate and adaptive immune dysfunction and provides an early prediction tool for clinical progression. medRxiv : the preprint server for health sciences. 2020 Article GET IT
- Mutation landscape, clonal evolution pattern, and potential pathogenic pathways in B-lymphoblastic transformation of follicular lymphoma. Leukemia. 2020 Academic Article GET IT
- Selective dysregulation of ROCK2 activity promotes aberrant transcriptional networks in ABC diffuse large B-cell lymphoma. Scientific reports. 2020 Academic Article GET IT
- Myeloid, mast cell, histiocytic and dendritic cell neoplasms and proliferations involving the spleen. Seminars in diagnostic pathology. 2020 Academic Article GET IT
- A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL. Blood advances. 2020 Academic Article GET IT
- Chronic myeloid neoplasms harboring concomitant mutations in myeloproliferative neoplasm driver genes (JAK2/MPL/CALR) and SF3B1. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2020 Academic Article GET IT
- A Novel JAK1 Mutant Breast Implant-Associated Anaplastic Large Cell Lymphoma Patient-Derived Xenograft Fostering Pre-Clinical Discoveries. Cancers. 2020 Academic Article GET IT
-
Myeloproliferative and lymphoproliferative malignancies occurring in the same patient: a nationwide discovery cohort.
Haematologica.
2019
Academic Article
GET IT
Times cited: 2 -
Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies.
Journal for immunotherapy of cancer.
2019
Academic Article
GET IT
Times cited: 4 -
Myeloid neoplasms with isolated del(5q) and JAK2 V617F mutation: a "grey zone" combination of myelodysplastic and myeloproliferative features?.
Haematologica.
2019
Letter
GET IT
Times cited: 2 -
Histiocytic Sarcoma Following B-Lymphoblastic Leukemia/Lymphoma.
American journal of clinical pathology.
2019
Academic Article
GET IT
Times cited: 2 -
Exploring tumor clonal evolution in bone marrow of patients with diffuse large B-cell lymphoma by deep IGH sequencing and its potential relevance in relapse.
Blood cancer journal.
2019
Letter
GET IT
Times cited: 2 -
Somatic mutations and cell identity linked by Genotyping of Transcriptomes.
Nature.
2019
Academic Article
GET IT
Times cited: 35 -
Digital droplet PCR and next-generation sequencing refine minimal residual disease monitoring in acute lymphoblastic leukemia.
Leukemia & lymphoma.
2019
Letter
GET IT
Times cited: 4 -
Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL.
Cancer immunology research.
2019
Academic Article
GET IT
Times cited: 20 -
PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Program.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
2019
Academic Article
GET IT
Times cited: 11 -
Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
2018
Academic Article
GET IT
Times cited: 14 -
TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell Lymphomagenesis.
Cancer discovery.
2018
Academic Article
GET IT
Times cited: 38 -
A multimodality work-up of patients with Hypereosinophilia.
American journal of hematology.
2018
Academic Article
GET IT
Times cited: 8 -
Five-year follow-up of lenalidomide plus rituximab as initial treatment of mantle cell lymphoma.
Blood.
2018
Academic Article
GET IT
Times cited: 35 -
Simple deep sequencing-based post-remission MRD surveillance predicts clinical relapse in B-ALL.
Journal of hematology & oncology.
2018
Academic Article
GET IT
Times cited: 11 -
Novel Richter Syndrome Xenograft Models to Study Genetic Architecture, Biology, and Therapy Responses.
Cancer research.
2018
Academic Article
GET IT
Times cited: 4 -
Assessment of the Utility of Cytology and Flow Cytometry of Cerebrospinal Fluid Samples in Clinical Practice.
Acta cytologica.
2018
Academic Article
GET IT
Times cited: 3 -
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML.
Blood.
2018
Academic Article
GET IT
Times cited: 70 -
MicroRNA-155 regulates casein kinase 1 gamma 2: a potential pathogenetic role in chronic lymphocytic leukemia.
Blood cancer journal.
2017
Letter
GET IT
Times cited: 6 -
An intrasinusoidal extracavitary variant of primary effusion lymphoma.
Blood.
2017
Academic Article
GET IT
Times cited: 3 -
Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy.
Leukemia.
2017
Academic Article
GET IT
Times cited: 17 -
Myelodysplastic Syndrome, Unclassifiable (MDS-U) With 1% Blasts Is a Distinct Subgroup of MDS-U With a Poor Prognosis.
American journal of clinical pathology.
2017
Academic Article
GET IT
Times cited: 6 -
AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma.
The American journal of pathology.
2017
Academic Article
GET IT
Times cited: 21 -
Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
2017
Academic Article
GET IT
Times cited: 24 -
The effect of initial molecular profile on response to recombinant interferon-α (rIFNα) treatment in early myelofibrosis.
Cancer.
2017
Academic Article
GET IT
Times cited: 25 -
Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome.
Haematologica.
2017
Academic Article
GET IT
Times cited: 18 -
CD4-Negative Variant of Cutaneous Blastic Plasmacytoid Dendritic Cell Neoplasm With a Novel PBRM1 Mutation in an 11-Year-Old Girl.
American journal of clinical pathology.
2017
Academic Article
GET IT
Times cited: 2 -
Dysregulation of Blimp1 transcriptional repressor unleashes p130Cas/ErbB2 breast cancer invasion.
Scientific reports.
2017
Academic Article
GET IT
Times cited: 10 -
BCL6 Antagonizes NOTCH2 to Maintain Survival of Human Follicular Lymphoma Cells.
Cancer discovery.
2017
Academic Article
GET IT
Times cited: 15 -
CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas.
Cancer discovery.
2016
Academic Article
GET IT
Times cited: 103 -
Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells.
Cell.
2016
Academic Article
GET IT
Times cited: 101 -
Cutaneous myeloid dendritic cell dyscrasia: A cutaneous clonal monocytosis associated with chronic myeloproliferative disorders and peripheral blood monocytosis.
Annals of diagnostic pathology.
2016
Academic Article
GET IT
Times cited: 5 -
Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma.
The Journal of clinical investigation.
2016
Academic Article
GET IT
Times cited: 71 -
Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care.
NPJ genomic medicine.
2016
Academic Article
GET IT
Times cited: 35 -
Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
2016
Academic Article
GET IT
Times cited: 44 -
Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma.
Oncotarget.
2016
Academic Article
GET IT
Times cited: 19 -
Pure Erythroid Leukemia Mimicking Ewing Sarcoma/Primitive Neuroectodermal Tumor in an Infant.
Pediatric blood & cancer.
2016
Academic Article
GET IT
Times cited: 4 -
VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma.
Journal of visualized experiments : JoVE.
2015
Academic Article
GET IT
Times cited: 12 -
EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis.
Leukemia.
2015
Academic Article
GET IT
Times cited: 34 -
Pharmacoproteomics identifies combinatorial therapy targets for diffuse large B cell lymphoma.
The Journal of clinical investigation.
2015
Academic Article
GET IT
Times cited: 28 -
Primary cutaneous follicle center lymphoma associated with an extracutaneous dissemination: a cytogenetic finding of potential prognostic value.
American journal of clinical pathology.
2015
Academic Article
GET IT
Times cited: 2 -
The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development.
Nature medicine.
2015
Academic Article
GET IT
Times cited: 172 -
Epigenomic evolution in diffuse large B-cell lymphomas.
Nature communications.
2015
Academic Article
GET IT
Times cited: 63 -
The tumor virus landscape of AIDS-related lymphomas.
Blood.
2015
Academic Article
GET IT
Times cited: 34 -
IL10 receptor is a novel therapeutic target in DLBCLs.
Leukemia.
2015
Academic Article
GET IT
Times cited: 35 -
Cyclin D1-positive diffuse large B-cell lymphoma with IGH-CCND1 translocation and BCL6 rearrangement: a report of two cases.
American journal of clinical pathology.
2015
Academic Article
GET IT
Times cited: 7 -
Massive splenic hamartoma with bizarre stromal cells.
International journal of hematology.
2015
Letter
GET IT
Times cited: 2 - Cryptococcosis in bone marrow following treatment for Hodgkin lymphoma. International journal of hematology. 2015 Letter GET IT
-
Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells.
Blood.
2014
Academic Article
GET IT
Times cited: 161 -
Lymphoblastic transformation of follicular lymphoma: a clinicopathologic and molecular analysis of 7 patients.
Human pathology.
2014
Academic Article
GET IT
Times cited: 35 -
Hypermethylation of the tumor suppressor gene PRDM1/Blimp-1 supports a pathogenetic role in EBV-positive Burkitt lymphoma.
Blood cancer journal.
2014
Academic Article
GET IT
Times cited: 16 -
Deep sequencing reveals clonal evolution patterns and mutation events associated with relapse in B-cell lymphomas.
Genome biology.
2014
Academic Article
GET IT
Times cited: 55 -
Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy.
The Journal of experimental medicine.
2014
Academic Article
GET IT
Times cited: 25 -
Inactivation of BANK1 in a novel IGH-associated translocation t(4;14)(q24;q32) suggests a tumor suppressor role in B-cell lymphoma.
Blood cancer journal.
2014
Letter
GET IT
Times cited: 5 -
Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance.
Cancer cell.
2014
Academic Article
GET IT
Times cited: 121 - Aberrantly sustained PAX5 expression in plasma cell differentiation is a frequent feature in lymphoplasmacytic lymphoma but not marginal zone lymphoma in bone marrow. Journal of Hematopathology. 2013 Article GET IT
-
The genetics of interdigitating dendritic cell sarcoma share some changes with Langerhans cell histiocytosis in select cases.
Annals of diagnostic pathology.
2013
Academic Article
GET IT
Times cited: 7 - Diffuse variant of lymphocyte-predominant Hodgkin lymphoma: A diagnostic challenge. Journal of Hematopathology. 2013 Article GET IT
-
MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.
Blood.
2013
Academic Article
GET IT
Times cited: 35 -
Mechanism-based epigenetic chemosensitization therapy of diffuse large B-cell lymphoma.
Cancer discovery.
2013
Academic Article
GET IT
Times cited: 109 -
Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2012
Academic Article
GET IT
Times cited: 20 -
Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes.
Blood.
2012
Academic Article
GET IT
Times cited: 67 -
Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL, and CD40L.
Journal of immunology (Baltimore, Md. : 1950).
2012
Academic Article
GET IT
Times cited: 53 -
Composite chronic lymphocytic leukemia/small lymphocytic lymphoma and follicular lymphoma are biclonal lymphomas: a report of two cases.
American journal of clinical pathology.
2012
Academic Article
GET IT
Times cited: 13 -
Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study.
Leukemia.
2012
Academic Article
GET IT
Times cited: 241 -
B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen.
Nature immunology.
2011
Academic Article
GET IT
Times cited: 413 -
The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma.
Cell.
2011
Academic Article
GET IT
Times cited: 121 -
A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma.
Blood.
2011
Academic Article
GET IT
Times cited: 24 -
Kaposi sarcoma herpesvirus (KSHV) vFLIP oncoprotein induces B cell transdifferentiation and tumorigenesis in mice.
The Journal of clinical investigation.
2011
Academic Article
GET IT
Times cited: 67 -
Transformation of follicular lymphoma to plasmablastic lymphoma with c-myc gene rearrangement.
American journal of clinical pathology.
2010
Academic Article
GET IT
Times cited: 29 -
Follicular dendritic cell-induced microRNA-mediated upregulation of PRDM1 and downregulation of BCL-6 in non-Hodgkin's B-cell lymphomas.
Leukemia.
2010
Academic Article
GET IT
Times cited: 61 -
Epigenetic down-regulation of the tumor suppressor gene PRDM1/Blimp-1 in diffuse large B cell lymphomas: a potential role of the microRNA let-7.
The American journal of pathology.
2010
Academic Article
GET IT
Times cited: 42 -
Histiocytic sarcoma with interdigitating dendritic cell differentiation: a case report with fine needle aspiration cytology and review of literature.
Diagnostic cytopathology.
2010
Academic Article
GET IT
Times cited: 19 -
Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia.
Nature cell biology.
2010
Academic Article
GET IT
Times cited: 253 -
MicroRNAs of the immune system: roles in inflammation and cancer.
Annals of the New York Academy of Sciences.
2010
Review
GET IT
Times cited: 127 -
Transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma to interdigitating dendritic cell sarcoma: evidence for transdifferentiation of the lymphoma clone.
American journal of clinical pathology.
2009
Academic Article
GET IT
Times cited: 62 -
Reticuloendotheliosis virus strain T induces miR-155, which targets JARID2 and promotes cell survival.
Journal of virology.
2009
Academic Article
GET IT
Times cited: 84 -
Diffuse blastoid B-cell lymphoma: a histologically aggressive variant of t(14;18)-negative follicular lymphoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
2009
Academic Article
GET IT
Times cited: 11 -
Micro-classifying diffuse large B-cell lymphomas.
Blood.
2009
Comment
GET IT
Times cited: 2 -
Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies.
Leukemia.
2009
Academic Article
GET IT
Times cited: 134 -
Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD).
Histopathology.
2008
Academic Article
GET IT
Times cited: 54 -
Tumorigenic activity and therapeutic inhibition of Rheb GTPase.
Genes & development.
2008
Academic Article
GET IT
Times cited: 86 -
The emergent role of microRNAs in molecular diagnostics of cancer.
The Journal of molecular diagnostics : JMD.
2008
Comment
GET IT
Times cited: 20 -
MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas.
The American journal of pathology.
2008
Academic Article
GET IT
Times cited: 131 -
Primary esophageal large T-cell lymphoma mimicking esophageal carcinoma: a case report and literature review.
The Journal of thoracic and cardiovascular surgery.
2008
Academic Article
GET IT
Times cited: 5 -
BIC is processed efficiently to microRNA-155 in Burkitt lymphoma cells.
Leukemia.
2008
Academic Article
GET IT
Times cited: 12 -
Significance of PRDM1beta expression as a prognostic marker in diffuse large B-cell lymphomas.
Blood.
2008
Letter
GET IT
Times cited: 7 - MicroRNAs in tumorigenesis: a primer. The American journal of pathology. 2007 Review GET IT
-
Concurrent invasive ductal carcinoma and chronic lymphocytic leukemia manifesting as a collision tumor in breast.
The breast journal.
2007
Academic Article
GET IT
Times cited: 24 -
A mammalian microRNA expression atlas based on small RNA library sequencing.
Cell.
2007
Academic Article
GET IT
Times cited: 2679 -
Lack of A563G (I188V) missense mutation in RIZ/ PRDM2 in human diffuse large B-cell lymphomas.
Genes, chromosomes & cancer.
2007
Letter
GET IT
Times cited: 6 -
miR-155/BIC as an oncogenic microRNA.
Genes, chromosomes & cancer.
2006
Letter
GET IT
Times cited: 95 -
Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas.
Blood.
2006
Academic Article
GET IT
Times cited: 180 -
Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice.
Cancer cell.
2005
Academic Article
GET IT
Times cited: 265 -
Accumulation of miR-155 and BIC RNA in human B cell lymphomas.
Proceedings of the National Academy of Sciences of the United States of America.
2005
Academic Article
GET IT
Times cited: 1120 -
Avian bic, a gene isolated from a common retroviral site in avian leukosis virus-induced lymphomas that encodes a noncoding RNA, cooperates with c-myc in lymphomagenesis and erythroleukemogenesis.
Journal of virology.
2002
Academic Article
GET IT
Times cited: 129 -
Identification and characterization of human BIC, a gene on chromosome 21 that encodes a noncoding RNA.
Gene.
2001
Academic Article
GET IT
Times cited: 187 -
bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA.
Molecular and cellular biology.
1997
Academic Article
GET IT
Times cited: 247